XML 25 R7.htm IDEA: XBRL DOCUMENT v3.26.1
Statement of Changes In Shareholders’ Equity - 9 months ended Dec. 31, 2025 - USD ($)
Class A
Ordinary shares
Class B
Ordinary shares
Share Subscription Receivable
Additional Paid-in Capital
Retained Earnings
Total
Balance at Mar. 20, 2025
Balance (in Shares) at Mar. 20, 2025        
Class B ordinary shares issued to Initial Shareholder [1],[2] $ 383 (25,000) 24,617
Class B ordinary shares issued to Initial Shareholder, (in shares) [1],[2]   3,833,333        
Accretion for Class A ordinary shares to redemption amount 5,476,346 5,476,346
Sale of 367,000 Private Placement Units $ 37 3,674,963 3,675,000
Sale of 367,000 Private Placement Units (In shares) 367,500          
Fair value of representative shares deferred until IPO $ 8 8
Fair value of representative shares deferred until IPO (In shares) 75,000          
Fair value of rights included in Public units 2,070,000 2,070,000
Allocated value of transaction costs to Class A shares 59,680 59,680
Receipt of proceeds for the issuance of founder shares 25,000 25,000
Net income 840,557 840,557
Balance at Dec. 31, 2025 $ 45 $ 383 $ 233,554 $ 840,557 $ 1,074,539
Balance (in Shares) at Dec. 31, 2025 442,500 3,833,333        
[1] Includes an aggregate of 500,000 Class B ordinary shares subject to forfeiture if the over-allotment is not exercised in full or in part by the underwriters. On September 26, 2025, the underwriters exercised their over-allotment option in full as part of the closing of the Initial Public Offering. As such, the 500,000 Class B ordinary shares are no longer subject to forfeiture (Note 5).
[2] This number has been retroactively adjusted to reflect the recapitalization of the Company in the form of the cancellation of 1 Class B ordinary share and the subsequent issuance of 3,833,333 Class B ordinary shares on June 27, 2025 (Note 5).